COINOTAG News reported on August 23 that US-listed Ethereum reserve company ETHZilla (formerly 180 Life Sciences) has amended and restated a sales agreement with Clear Street LLC, electing to periodically issue and sell common stock through Clear Street acting as sales agent, with aggregate proceeds capped at up to $10 billion.
Under the initial sales agreement, the company has already issued and sold 5,001,310 shares, generating approximately $34.4 million in gross proceeds, according to the filing; these figures reflect completed transactions rather than forward-looking estimates.
The filing further states that, from the date of the prospectus supplement, ETHZilla will cease offering common stock pursuant to the market issuance prospectus submitted on August 13, 2025, aligning its capital-raising framework with the amended agreement.